πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 1,164 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9415105

Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Aug 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9409994

High-affinity monoclonal antibodies to glypican-3 and use thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Aug 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9409992

Mesothelin domain-specific monoclonal antibodies and use thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Aug 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9409956

Salmonella typhi Ty21a expressing Yersinia pestis F1-V fusion protein and uses thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Aug 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9402889

Live, oral vaccine for protection against Shigella dysenteriae serotype 1

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Aug 02 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9402820

Use of pyruvate or succinate to enhance the efficacy of a hypoxia activated prodrug for th

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Aug 02 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9399672

Hepatitis C virus neutralizing antibody

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jul 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9394364

Human monoclonal antibodies specific for glypican-3 and use thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jul 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9394358

Gene signature for predicting prognosis of patients with solid tumors

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jul 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9394352

Immunogenic POTE peptides and methods of use

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jul 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9394316

Inhibitors of the plasmodial surface anion channel as antimalarials

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jul 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9388222

Modified Pseudomonas exotoxin A

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jul 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9382311

HIV-1 broadly neutralizing antibodies

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jul 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 30 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9364557

Fold-back diabody diphtheria toxin immunotoxin and methods of use

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jun 14 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 09 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9364448

Nitisinone for treatment of oculocutaneous/ocular albinism and for increasing pigmentation

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jun 14 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 09 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9358285

Granulysin in immunotherapy

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jun 07 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 02 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9359418

Inhibitors of the T cell-specific alternative p38 activation pathway and methods of use

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jun 07 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 02 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9359447

Anti-mesothelin chimeric antigen receptors

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jun 07 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 02 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9353353

Virus-like particles (VLPs) prepared from chikungunya virus structural proteins

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9346859

Pseudomonas exotoxin A with less immunogenic T cell and/or B cell epitopes

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue May 24 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 19 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9345748

Anti-SSX-2 T cell receptors and related materials and methods of use

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue May 24 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 19 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9341619

Hyposialylation disorders

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue May 17 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 12 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9333251

Vaccine for protection against Shigella sonnei disease

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue May 10 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 05 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9326950

Self-assembling nanoparticles composed of transmembrane peptides and their application for

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue May 03 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted